Last reviewed · How we verify
NCT05865314: NutriPhyT
Optimised Nutritional Therapy and Early Physiotherapy in Long Term ICU Patients (NutriPhyT Trial)
NA trial testing Optimisation of nutrition therapy coupled with early mobilisation in Critical Illness in 164 participants. Currently enrolling.
1 June 2026
Quick facts
| Lead sponsor | HEIDEGGER CP |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 164 |
| Start date | 1 May 2023 |
| Primary completion | 1 June 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Optimisation of nutrition therapy coupled with early mobilisation
- Standard care — full drug profile →
Conditions studied
- Critical Illness — all drugs for Critical Illness →
- ICU Acquired Weakness — all drugs for ICU Acquired Weakness →
- Malnutrition — all drugs for Malnutrition →
Sponsor
HEIDEGGER CP
Who can join
18 and older, any sex, with Critical Illness or ICU Acquired Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Due to medical advances and quality of care, mortality in adult intensive care units (ICUs) has decreased significantly in recent years, leading to a significant increase in the number of patients with high rehabilitation needs on discharge from the ICU. A specific management by a multidisciplinary team has been set up since 2017 at the Geneva-ICU for long-stay patients (hospitalised ≥ 7 days). This study aim to assess whether an optimization of the nutritional therapy coupled with an early mobility during and after the ICU stay allows an improvement in the muscle function at hospital discharge compared to patients receiving the standard care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Personalized nutrition therapy in critical care: 10 expert recommendations.
Wischmeyer PE, Bear DE, Berger MM, De Waele E, et al · · 2023 · cited 69× · PMID 37403125 · DOI 10.1186/s13054-023-04539-x
Verify or expand the search:
- PubMed search for NCT05865314
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Critical Illness
Currently open trials in the same condition.
- NCT06189924 — Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients · recruiting
- NCT07418242 — Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients · recruiting
- NCT07101640 — PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysp · Phase 1, PHASE2 · recruiting
- NCT07177183 — Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure · NA · recruiting
- NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
Other HEIDEGGER CP trials
Trials by the same sponsor.
- NCT07343440 — Trial on the Impact of Indirect Calorimetry-Guided Nutritional Support on Patient-Centered Outcomes in Critically Ill Pa · NA · not yet recruiting
- NCT03890432 — GLUCOSAFE 2 - A New Tool for Nutritional Management and Insulin-therapy in the Intensive Care Unit (ICU) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05865314 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HEIDEGGER CP
- Last refreshed: 12 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05865314.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing